Next Article in Journal
Effectiveness, Safety, and Real-World Experience of Brolucizumab: A Systematic Review
Previous Article in Journal
The SP1-SuperEnhancer-SPHK1 Axis Mediates Niraparib Resistance in TNBC
Previous Article in Special Issue
Prognostic Factors and Talaporfin Sodium Concentration in Photodynamic Therapy for Recurrent Grade 4 Glioma
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(11), 1623; https://doi.org/10.3390/ph18111623
Action Date Notes Link
article html file updated 5 December 2025 20:02 CET Update https://www.mdpi.com/1424-8247/18/11/1623/html
article html file updated 28 October 2025 10:14 CET Update -
article pdf uploaded. 28 October 2025 10:10 CET Updated version of record https://www.mdpi.com/1424-8247/18/11/1623/pdf
article xml uploaded. 28 October 2025 10:10 CET Update https://www.mdpi.com/1424-8247/18/11/1623/xml
article xml file uploaded 28 October 2025 10:10 CET Update -
article html file updated 27 October 2025 15:13 CET Original file -
article supplementary file uploaded. 27 October 2025 15:11 CET - https://www.mdpi.com/1424-8247/18/11/1623#supplementary
article pdf uploaded. 27 October 2025 15:11 CET Version of Record https://www.mdpi.com/1424-8247/18/11/1623/pdf-vor
article xml uploaded. 27 October 2025 15:11 CET Update -
article xml file uploaded 27 October 2025 15:11 CET Original file -
Back to TopTop